Overview and Scope
Immunodiagnostics refers to a diagnostic methodology that relies primarily on an antigen-antibody response for the detection of serum insulin. Immunodiagnostic tests are used to detect antibodies and parasite antigens.
Sizing and Forecast
The immunodiagnostics market size has grown strongly in recent years. It will grow from $21.3 billion in 2023 to $22.9 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing incidence of infectious diseases, rise in autoimmune diseases, cancer diagnosis and monitoring, globalization of infectious diseases, public health initiatives and screening programs.
The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $30.9 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to pandemic preparedness and response, personalized medicine and biomarker discovery, growing healthcare infrastructure in emerging markets, integration with laboratory information systems, rising burden of chronic diseases. Major trends in the forecast period include multiplexing technologies, point-of-care testing (poct), biomarker discovery and personalized medicine, rise of digital immunodiagnostics, shift towards liquid biopsy.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Segmentation & Regional Insights
The immunodiagnostics market covered in this report is segmented –
1) By Product: Reagents And Consumables, Instruments, Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
North America was the largest region in the immunodiagnostics market in 2023. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of infectious diseases is expected to boost the growth of the immunodiagnostics market going forward. Infectious diseases refer to illnesses that transmit between people and are brought on by germs like viruses, bacteria, fungi, or parasites. An immunodiagnostic assay is used to identify a virus present in a blood sample. Hence, the increasing prevalence of infectious diseases is expected to boost the immunodiagnostics market. For instance, in July 2022, according to a report published by the Australian Institute of Health and Welfare, an Australia-based statutory agency that offers data and statistics about Australia’s well-being and health, there were over 471,000 COVID-19 cases reported in Australia in 2021. Further, in 2021, there were around 86,000 cases of chlamydia, a sexually transmitted infection, and cases of campylobacter, a gastrointestinal illness, increased to 37,000. Therefore, the increasing prevalence of infectious diseases is driving the growth of the immunodiagnostics market.
Key Industry Players
Major companies operating in the immunodiagnostics market report are Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation
The immunodiagnostics market report table of contents includes:
- Executive Summary
- Immunodiagnostics Market Characteristics
- Immunodiagnostics Market Trends And Strategies
- Immunodiagnostics Market – Macro Economic Scenario
- Global Immunodiagnostics Market Size and Growth
- Immunodiagnostics Market Segmentation
- Immunodiagnostics Market Regional And Country Analysis
………………
- Key Mergers And Acquisitions In The Immunodiagnostics Market
- Immunodiagnostics Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…………….
Table 75: Abbott Laboratories Financial Performance
Table 76: Arkray Inc. Financial Performance
Table 77: bioMérieux Inc. Financial Performance
Table 78: Immunodiagnostic Systems Holdings Plc (IDS) Financial Performance
Table 79: Bio-Rad Laboratories Inc. Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/electrocardiograph-ecg-market-size/
https://topprnews.com/cyberknife-market-growth/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
